ExodusPoint Capital Management’s iRadimed IRMD Stock Holding History

ExodusPoint Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.48M	Buy	+15,423	New	+$1.54M	0.01%	878
2024 Q4	–	Sell	-7,541	Closed	-$379K	–	1759
2024 Q3	$379K	Sell	7,541 -1,446	-16%	-$66.7K	﹤0.01%	1287
2024 Q2	$395K	Buy	+8,987	New	+$382K	﹤0.01%	1267
2019 Q4	–	Sell	-14,300	Closed	-$301K	–	1700
2019 Q3	$301K	Buy	+14,300	New	+$292K	0.01%	875

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's IRMD Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in iRadimed (IRMD) in Q1 2026: 15,423 shares worth $1.48M. The stake represents 0.01% of the portfolio and ranks #878 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in IRMD as recently as Q3 2024.

ExodusPoint Capital Management first reported a position in IRMD in Q3 2019 and has held it in 4 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

ExodusPoint Capital Management held 15,423 shares of iRadimed worth $1.48M as of Q1 2026.
iRadimed was a new ExodusPoint Capital Management position in Q1 2026.
iRadimed made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #878 holding.
ExodusPoint Capital Management first reported a position in iRadimed in Q3 2019 and has held it in 4 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.